Amit Mahipal

University Hospitals Cleveland Medical Center, Seidman Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Tinengotinib for Adult Patients with Advanced or Metastatic Cholangiocarcinoma: A Multicenter, Open-Label Phase 2 Trial

Number of pages: 49 Posted: 25 Mar 2025
Milind Javle, Christos Fountzilas, Chih-Yi (Andy) Liao, Meredith Pelster, Daneng Li, Dustin Deming, Vaibhav Sahai, Lionel Aurelien Kankeu Fonkoua, Allen Cohn, Parvez Mantry, Donald Richards, Edwin Kingsley, Frank Wu, Peng Peng, Katie Hennessy, Angie Sun, Shumao Ni, Jean Fan and Amit Mahipal
University of Texas at Houston - MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center - Department of Medicine, University of Chicago - Division of Biological Sciences, Sarah Cannon Research Institute, City of Hope - Comprehensive Cancer Center, University of Wisconsin-Madison, University of Michigan at Ann Arbor, Mayo Clinic College of Medicine and Science, Rocky Mountain Cancer Centers, Methodist Dallas Medical Center, Texas Oncology, Comprehensive Cancer Centers of Nevada, TransThera Sciences (Nanjing), Inc., TransThera Sciences (Nanjing), Inc., TransThera Sciences (Nanjing), Inc., TransThera Sciences (Nanjing), Inc., TransThera Sciences (Nanjing), Inc., TransThera Sciences (Nanjing), Inc. and University Hospitals Cleveland Medical Center, Seidman Cancer Center
Downloads 49 (869,684)

Abstract:

Loading...

cholangiocarcinoma, intrahepatic, FGFR, FGFR2, FGFR inhibotor